Skip to main content

Table 4 Multivariate analyses of factors associated with bone metastasis in 157 HCC patients

From: Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

Variable Bone metastasis
HR (95% CI) P
Vascular invasion (no versus yes) 6.625(2.291–19.157) < 0.001
BCLC stage (0-A versus B-C) 3.910(1.244–12.287) 0.020
Lnc34a (low versus high) 3.883(1.107–13.629) 0.034
  1. HCC hepatocellular carcinoma, BCLC-stage Barcelona Clinic Liver Cancer-stage